VCN Biosciences, S.L.   Report issue

For profit Phase 1
Founded: Barcelona Spain (2009)
Status: Acquired by Synthetic Biologics (2022)

Organization Overview

First Clinical Trial
2014
NCT02045589
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

VCN Biosciences, S.L.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 1)

Carcinoma (Phase 1)

Carcinoma, Squamous Cell (Phase 1)

Head and Neck Neoplasms (Phase 1)

Neoplasms (Phase 1)

Recurrence (Phase 1)

Squamous Cell Carcinoma of Head and Neck (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 5